CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: While the low level of engraftment typical of chronic phase CML CD34+ cells does not allow for survival experiments to be conducted, this model is the gold-standard to assess human LSC survival due to the long-term engraftment and well-defined stem cell population.